This compound is primarily used in the field of medicinal chemistry and drug development. It serves as a key intermediate in the synthesis of biologically active molecules, particularly those targeting enzyme inhibition or receptor modulation. Its boronate ester functionality makes it valuable in Suzuki-Miyaura cross-coupling reactions, a widely used method for constructing carbon-carbon bonds in pharmaceutical research. Additionally, it is employed in the development of proteolysis-targeting chimeras (PROTACs), which are innovative therapeutic agents designed to degrade specific disease-causing proteins. Its structural features also make it suitable for use in the preparation of boron-containing compounds, which are increasingly explored for their potential in cancer therapy and imaging applications.